arrow

Product

Sold By

north shore

CelProtect

bigStar

0 Customer Ratings

Price

AUD 63.53

Number of Views: 1

Available in
Countries: Australia, Belgium, Canada, Switzerland, Germany, Denmark, Spain, Finland, France, United Kingdom, Hong Kong, Ireland, Italy, South Korea, Netherlands, Norway, New Zealand, Poland, Portugal, Sweden, Singapore, United States,

View Product on the Shop

100 x 500mg Capsules Ingredients CelProtect contains a unique combination of chemo-preventive polyphenols that promote antitumor immune activity. CelProtect provides anti-oxidant, and is a potent inhibitor of angiogenesis - a critical function for tumour survival. Ingredients Pueraria lobata (root) (contains: Daidzein) Glycine max (seed) (contains: Glycitein and Genistein) Scutellariae baicalensis (root) (contains: Baicalein and Baicalin) Gardenia jasminoides (fruit) Other Ingredients:Vegetable cellulose (hypromellose); Vegetable Stearic Acid; Microcrystalline Cellulose and Vegetable Magnesium Stearate. DoesNotContain: Wheat, gluten, milk, eggs, fish, crustacean shellfish, tree nuts, peanuts Actions & Indications CelProtect100 x 500mg CapsulesActions Anti-inflammatoryEnhances immunologic functionsInhibits angiogenesisAnti-tumouralIndications Inflammatory conditionsIImmunologic deficienciesProstate cancerBreast cancerColon cancer kin cancerRenal cell carcinomaLymphomaSuggested Use:2 to 5 caps 1 to 2 times dailyCaution:If the Gleason grade is above 2 and the total score is greater than 6, Genistein (CelProtect) is only to be used with radio and/or chemotherapy.CelProtect may enhance these treatments. Below these levels CelProtect is the recommended protocol and hormone therapy is NOT recommended.Warning:Contraindicated in pregnancy and breast-feeding. May be contraindicated with estrogen dependant breast cancer depending on dosage.CelProtect may potentiate the effect of hypoglycemic medications and insulin and could lead to enhanced drug effects and hypoglycaemia.Diabetes Type 1 - potential to interfere with insulinDiabetes Type 2-potential to interfere with hypoglycaemic drugs / and insulinPrescribe cautiously and monitor blood sugar regularly. The patient needs to be warned about the potential hypoglycemic effects and their medication may need to be adjusted (reduced) as necessary in conjunction with their prescribing practitioner.


Subscribe to Our Newsletter

For frequent updates and offers please subscribe to our newsletter!

Select Language

Powered by Google Translator

Copyright @2026. All rights reserved.